dechra pharmaceuticals holdings limited
dechra pharmaceuticals holdings limited Company Information
Company Number
14856770
Next Accounts
Mar 2026
Shareholders
dechra group holdings limited
Group Structure
View All
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Registered Address
24 cheshire avenue, cheshire business park, northwich, CW9 7UA
Website
-dechra pharmaceuticals holdings limited Estimated Valuation
Pomanda estimates the enterprise value of DECHRA PHARMACEUTICALS HOLDINGS LIMITED at £7.5m based on a Turnover of £3.3m and 2.3x industry multiple (adjusted for size and gross margin).
dechra pharmaceuticals holdings limited Estimated Valuation
Pomanda estimates the enterprise value of DECHRA PHARMACEUTICALS HOLDINGS LIMITED at £0 based on an EBITDA of £-6.6m and a 9.53x industry multiple (adjusted for size and gross margin).
dechra pharmaceuticals holdings limited Estimated Valuation
Pomanda estimates the enterprise value of DECHRA PHARMACEUTICALS HOLDINGS LIMITED at £5.5b based on Net Assets of £4.1b and 1.34x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dechra Pharmaceuticals Holdings Limited Overview
Dechra Pharmaceuticals Holdings Limited is a live company located in northwich, CW9 7UA with a Companies House number of 14856770. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in May 2023, it's largest shareholder is dechra group holdings limited with a 100% stake. Dechra Pharmaceuticals Holdings Limited is a startup, small sized company, Pomanda has estimated its turnover at £3.3m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Dechra Pharmaceuticals Holdings Limited Health Check
Pomanda's financial health check has awarded Dechra Pharmaceuticals Holdings Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
0 Regular
5 Weak
Size
annual sales of £3.3m, make it smaller than the average company (£19.6m)
£3.3m - Dechra Pharmaceuticals Holdings Limited
£19.6m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Dechra Pharmaceuticals Holdings Limited
- - Industry AVG
Production
with a gross margin of 100%, this company has a lower cost of product (35.2%)
100% - Dechra Pharmaceuticals Holdings Limited
35.2% - Industry AVG
Profitability
an operating margin of -202.5% make it less profitable than the average company (4.7%)
-202.5% - Dechra Pharmaceuticals Holdings Limited
4.7% - Industry AVG
Employees
with 8 employees, this is below the industry average (106)
8 - Dechra Pharmaceuticals Holdings Limited
106 - Industry AVG
Pay Structure
on an average salary of £254.2k, the company has a higher pay structure (£45.4k)
£254.2k - Dechra Pharmaceuticals Holdings Limited
£45.4k - Industry AVG
Efficiency
resulting in sales per employee of £407.8k, this is more efficient (£194.7k)
£407.8k - Dechra Pharmaceuticals Holdings Limited
£194.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Dechra Pharmaceuticals Holdings Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Dechra Pharmaceuticals Holdings Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Dechra Pharmaceuticals Holdings Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (13 weeks)
2 weeks - Dechra Pharmaceuticals Holdings Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 13.3%, this is a lower level of debt than the average (68.8%)
13.3% - Dechra Pharmaceuticals Holdings Limited
68.8% - Industry AVG
DECHRA PHARMACEUTICALS HOLDINGS LIMITED financials
Dechra Pharmaceuticals Holdings Limited's latest turnover from June 2024 is £3.3 million and the company has net assets of £4.1 billion. According to their latest financial statements, Dechra Pharmaceuticals Holdings Limited has 8 employees and maintains cash reserves of £1.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2024 | |
|---|---|
| Turnover | 3,262,339 |
| Other Income Or Grants | |
| Cost Of Sales | |
| Gross Profit | 3,262,339 |
| Admin Expenses | 9,868,154 |
| Operating Profit | -6,605,815 |
| Interest Payable | 28,943,543 |
| Interest Receivable | 11,088,573 |
| Pre-Tax Profit | -24,460,784 |
| Tax | 24,510 |
| Profit After Tax | -24,436,274 |
| Dividends Paid | |
| Retained Profit | -24,436,274 |
| Employee Costs | 2,033,469 |
| Number Of Employees | 8 |
| EBITDA* | -6,605,815 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2024 | |
|---|---|
| Tangible Assets | |
| Intangible Assets | |
| Investments & Other | 4,465,461,460 |
| Debtors (Due After 1 year) | |
| Total Fixed Assets | 4,465,461,460 |
| Stock & work in progress | |
| Trade Debtors | |
| Group Debtors | 227,483,941 |
| Misc Debtors | |
| Cash | 1,373,394 |
| misc current assets | 5,621,197 |
| total current assets | 234,478,533 |
| total assets | 4,699,939,993 |
| Bank overdraft | |
| Bank loan | |
| Trade Creditors | |
| Group/Directors Accounts | 4,577,417 |
| other short term finances | |
| hp & lease commitments | |
| other current liabilities | 27,434,077 |
| total current liabilities | 32,011,494 |
| loans | 592,576,910 |
| hp & lease commitments | |
| Accruals and Deferred Income | |
| other liabilities | |
| provisions | 440,331 |
| total long term liabilities | 593,017,241 |
| total liabilities | 625,028,736 |
| net assets | 4,074,911,258 |
| total shareholders funds | 4,074,911,258 |
| Jun 2024 | |
|---|---|
| Operating Activities | |
| Operating Profit | -6,605,815 |
| Depreciation | |
| Amortisation | |
| Tax | 24,510 |
| Stock | |
| Debtors | 227,483,941 |
| Creditors | |
| Accruals and Deferred Income | 27,434,077 |
| Deferred Taxes & Provisions | 440,331 |
| Cash flow from operations | -206,190,838 |
| Investing Activities | |
| capital expenditure | |
| Change in Investments | 4,465,461,460 |
| cash flow from investments | |
| Financing Activities | |
| Bank loans | |
| Group/Directors Accounts | 4,577,417 |
| Other Short Term Loans | |
| Long term loans | 592,576,910 |
| Hire Purchase and Lease Commitments | |
| other long term liabilities | |
| share issue | |
| interest | -17,854,970 |
| cash flow from financing | 4,678,646,889 |
| cash and cash equivalents | |
| cash | 1,373,394 |
| overdraft | |
| change in cash | 1,373,394 |
dechra pharmaceuticals holdings limited Credit Report and Business Information
Dechra Pharmaceuticals Holdings Limited Competitor Analysis
Perform a competitor analysis for dechra pharmaceuticals holdings limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other small companies, companies in CW9 area or any other competitors across 12 key performance metrics.
dechra pharmaceuticals holdings limited Ownership
DECHRA PHARMACEUTICALS HOLDINGS LIMITED group structure
Dechra Pharmaceuticals Holdings Limited has 1 subsidiary company.
Ultimate parent company
FREYA POOLCO SARL
#0168355
2 parents
DECHRA PHARMACEUTICALS HOLDINGS LIMITED
14856770
1 subsidiary
dechra pharmaceuticals holdings limited directors
Dechra Pharmaceuticals Holdings Limited currently has 3 directors. The longest serving directors include Miss Melanie Hall (Feb 2024) and Mr Paul Sandland (Feb 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Miss Melanie Hall | United Kingdom | 55 years | Feb 2024 | - | Director |
| Mr Paul Sandland | England | 46 years | Feb 2024 | - | Director |
| Mr Jesper Nordengaard | United Kingdom | 49 years | Sep 2024 | - | Director |
P&L
June 2024turnover
3.3m
0%
operating profit
-6.6m
0%
gross margin
100%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
4.1b
0%
total assets
4.7b
0%
cash
1.4m
0%
net assets
Total assets minus all liabilities
Similar Companies
dechra pharmaceuticals holdings limited company details
company number
14856770
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
May 2023
age
2
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
June 2024
previous names
freya bidco limited (March 2024)
accountant
-
auditor
-
address
24 cheshire avenue, cheshire business park, northwich, CW9 7UA
Bank
-
Legal Advisor
-
dechra pharmaceuticals holdings limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to dechra pharmaceuticals holdings limited. Currently there are 1 open charges and 2 have been satisfied in the past.
dechra pharmaceuticals holdings limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DECHRA PHARMACEUTICALS HOLDINGS LIMITED. This can take several minutes, an email will notify you when this has completed.
dechra pharmaceuticals holdings limited Companies House Filings - See Documents
| date | description | view/download |
|---|
